Skip to main content

Advertisement

SpringerLink
Log in

Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Fett N, Werth VP (2011) Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 64:217–228

    Article  Google Scholar 

  2. Peroni A, Zini A, Braga V, Colato C, Adami S, Girolomoni G (2008) Drug-induced morphea: report of a case induced by balicatib and review of the literature. J Am Acad Dermatol 59:125–129

    Article  Google Scholar 

  3. Balegar S, Mishra DK, Chatterjee S, Kumari S, Tiwary AK (2016) Generalized morphea following radiotherapy for an intracranial tumor. Indian J Dermatol 61:581

    Article  Google Scholar 

  4. Caccavale S, Caccavale T, La Montagna M (2017) A case of morphea following radiotherapy for an intracranial tumor: an example of isoradiotopic response. Indian J Dermatol 62:92–93

    Article  Google Scholar 

  5. Ransohoff JD, Kwong BY (2017) Cutaneous adverse events of targeted therapies for hematolymphoid malignancies. Clin Lymphoma Myeloma Leuk 17:834–851

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Dermatology, Dokuz Eylul University, 35340 Inciraltı, Izmir, Turkey

    Ozlem Ozbagcivan, Sevgi Akarsu, Ecem Canturk Nazli & Emel Fetil

  2. Faculty of Medicine, Department of Pathology, Dokuz Eylul University, Izmir, Turkey

    Banu Lebe

Authors
  1. Ozlem Ozbagcivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sevgi Akarsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ecem Canturk Nazli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Banu Lebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emel Fetil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ozlem Ozbagcivan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

A written informed consent was obtained from the patient.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ozbagcivan, O., Akarsu, S., Nazli, E.C. et al. Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia. Ann Hematol 100, 293–294 (2021). https://doi.org/10.1007/s00277-020-04009-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04009-2

Search

Navigation